Surveillance Study of Drug Therapy in Patients with Acromegaly

What we are studying

The purpose of this study is to assess those patients with acromegaly (hormonal disorder due to excess production of growth hormone from the pituitary gland) who are being treated with a drug therapy. Our goal is to collect symptoms and outcomes data in hopes of providing valuable information about acromegaly and its treatment.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Patients diagnosed with acromegaly who have undergone conventional treatment and still have persistent symptoms

What is involved

  • Requires no extra study-related visits
  • Involves only monitoring of your normal treatment under your doctor's supervision

Compensation

Participants will not be paid for this study.

Contact Information

Study Coordinator
Charlotte Miller
Email
chmiller@wakehealth.edu
Phone
336-716-4031

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.